Thrombolytic therapy of acute myocardial infarction: Trials, trials, and more trials
نویسندگان
چکیده
منابع مشابه
Tenecteplase versus reteplase in acute myocardial infarction: A network meta-analysis of randomized clinical trials
Background: Acute myocardial infarction (AMI) is the leading cause of death throughout the world. One of the standard approaches to treatment of AMI is fibrinolysis. The study was conducted to evaluate the clinical efficacy of tenecteplase versus reteplase through network meta-analysis for AMI. Methods: Randomized trials were comprehensively searched in PubMed, Scopus, Cochrane library, a...
متن کاملTenecteplase versus reteplase in acute myocardial infarction: A network meta-analysis of randomized clinical trials
Background: Acute myocardial infarction (AMI) is the leading cause of death throughout the world. One of the standard approaches to treatment of AMI is fibrinolysis. The study was conducted to evaluate the clinical efficacy of tenecteplase versus reteplase through network meta-analysis for AMI. Methods: Randomized trials were comprehensively searched in PubMed, Scopus, Cochrane library, a...
متن کاملVentricular arrhythmias in trials of thrombolytic therapy for acute myocardial infarction. A meta-analysis.
BACKGROUND Although thrombolytic therapy reduces long-term mortality in acute myocardial infarction, many clinicians remain concerned about an increased risk of ventricular arrhythmias associated with the use of these agents. METHODS AND RESULTS To determine whether thrombolytic therapy increases the risk of ventricular tachyarrhythmias and whether an increase in arrhythmias could be responsi...
متن کاملParticipation in thrombolytic trials delays reperfusion therapy in acute myocardial infarction.
BACKGROUND Shortening the time delay at the beginning of treatment in ST-segment elevation myocardial infarction (STEMI) has proven to be clinically essential. Invasive vs. thrombolytic treatment strategy is currently under investigation, particularly in terms of the time from the onset of symptoms to treatment initiation. It is likely that enrolment to trials in STEMI may paradoxically prolong...
متن کاملStent trials in acute myocardial infarction.
myocardial infarction has been demonstrated to reduce in-hospital major adverse events. PTCA has been shown to result in lower rates of mortality, recurrent myocardial infarction and stroke than t h r o m b o l y s i s . – 3 Furthermore, this result was also demonstrated in the GUSTO IIB trial, the largest randomized comparison between PTCA and thrombolysis. However, recurrent ischemia, early r...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Clinical Cardiology
سال: 1991
ISSN: 0160-9289,1932-8737
DOI: 10.1002/clc.4960140402